Spencer R. Berthelsen - 20 Jun 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Spencer R. Berthelsen
Issuer symbol
IONS
Transactions as of
20 Jun 2023
Net transactions value
+$320,288
Form type
4
Filing time
22 Jun 2023, 17:17:12 UTC
Previous filing
19 Jul 2022
Next filing
06 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Options Exercise $320,288 +11,250 +8.7% $28.47 140,147 20 Jun 2023 Direct F1
holding IONS Common Stock 70 20 Jun 2023 by Daughter F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Non-Qualified Stock Option (right to buy) Options Exercise $0 -11,250 -100% $0.000000* 0 20 Jun 2023 Common Stock 11,250 $28.47 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2023
F2 The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.